CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,033,000 | +108.3% | 20,000 | 0.0% | 0.73% | +101.4% |
| Q2 2022 | $496,000 | -1.0% | 20,000 | 0.0% | 0.36% | 0.0% |
| Q1 2022 | $501,000 | -31.2% | 20,000 | 0.0% | 0.36% | -23.0% |
| Q4 2021 | $728,000 | +70.1% | 20,000 | -20.0% | 0.47% | +61.2% |
| Q3 2021 | $428,000 | +6.5% | 25,000 | -16.7% | 0.29% | +21.2% |
| Q2 2021 | $402,000 | -73.8% | 30,000 | 0.0% | 0.24% | -73.7% |
| Q1 2021 | $1,537,000 | -17.3% | 30,000 | 0.0% | 0.91% | -14.8% |
| Q4 2020 | $1,858,000 | -43.5% | 30,000 | -50.0% | 1.07% | -2.6% |
| Q3 2020 | $3,288,000 | +90.5% | 60,000 | +100.0% | 1.10% | +5.3% |
| Q2 2020 | $1,726,000 | +43.2% | 30,000 | 0.0% | 1.04% | -2.4% |
| Q1 2020 | $1,205,000 | +21.8% | 30,000 | +20.0% | 1.07% | +48.7% |
| Q4 2019 | $989,000 | – | 25,000 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |